Isomäki O, Vuento R, Granfors K
Department of Medical Microbiology, Turku University, Finland.
Lancet. 1989 Jun 24;1(8652):1411-4. doi: 10.1016/s0140-6736(89)90124-4.
An enzyme immunoassay (EIA) for the detection and measurement of serum IgM, IgG, and IgA antibodies to salmonella was developed with commercially available lipopolysaccharides (LPSs) of Salmonella typhimurium and S enteritidis combined as antigen. Of 130 sera from patients with culture-confirmed salmonella infections, 115 (88.5%) were positive in this assay. The classic Widal agglutination test was positive in only 50 (38.5%) cases. This EIA method offers a substantial advance in the serological diagnosis of acute salmonella infections; it detects antibodies to the salmonellae of groups B and D, which constitute about 70% of culture-positive cases of human salmonellosis. Antibodies to other salmonellae are also detected. This EIA is particularly valuable for the detection of salmonella antibodies during post-infectious complications when isolation of the organism is often no longer possible.
利用鼠伤寒沙门氏菌和肠炎沙门氏菌的市售脂多糖(LPS)组合作为抗原,开发了一种用于检测和测量血清中抗沙门氏菌IgM、IgG和IgA抗体的酶免疫测定(EIA)方法。在130份经培养确诊为沙门氏菌感染患者的血清中,该检测方法有115份(88.5%)呈阳性。经典的肥达凝集试验仅在50例(38.5%)中呈阳性。这种EIA方法在急性沙门氏菌感染的血清学诊断方面取得了重大进展;它能检测到B组和D组沙门氏菌的抗体,这两组沙门氏菌约占人类沙门氏菌病培养阳性病例的70%。其他沙门氏菌的抗体也能被检测到。这种EIA对于在感染后并发症期间检测沙门氏菌抗体特别有价值,因为此时往往无法再分离出该病原体。